Dr. KAUSTUBH MULAY

Dr. FAIROOZ PUTHIYAPURAYIL MANJANDAVIDA, Dr.Vikas Menon, Dr. SANTOSH G. HONAVAR

Abstract

Myxoid neoplasms and proliferations of the conjunctiva are rare and often have overlapping clinicopathological features. Given that a subset of these are associated with Carney Complex, their timely diagnosis and distinction from each other is crucial. Conjunctival stromal tumor (COST) is once such recently described, benign, mesenchymal proliferation of uncertain aetiology and conflicting nosology. It is typically composed of CD34-positive spindle-shaped cells embedded in an abundantly myxoid stroma with multinucleate giant cells and pseudonuclear inclusions in some. Given its indolent clinical course, complete surgical excision with clear margins is the treatment of choice. We report a series of 10, biopsy-proven COSTs with their clinicopathological features, immunohistochemical findings and patient outcomes and also review the literature on them.